Nomura Asset Management
TEVA icon

Nomura Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Nomura Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13M Buy
384,707
+20,120
+6% +$670K 0.03% 410
2026
Q1 		$11M Hold
364,587
– – 0.03% 422
2025
Q4 		$11.4M Buy
364,587
+15,349
+4% +$378K 0.03% 411
2025
Q3 		$7.05M Hold
349,238
– – 0.02% 514
2025
Q2 		$5.85M Buy
349,238
+22,300
+7% +$360K 0.02% 561
2025
Q1 		$5.03M Buy
326,938
+16,000
+5% +$286K 0.02% 576
2024
Q4 		$6.85M Sell
310,938
-2,300
-0.7% -$41.8K 0.02% 500
2024
Q3 		$5.64M Buy
313,238
+22,400
+8% +$392K 0.02% 549
2024
Q2 		$4.73M Sell
290,838
-1,800
-0.6% -$27.7K 0.02% 556
2024
Q1 		$4.13M Sell
292,638
-57,292
-16% -$722K 0.02% 577
2023
Q4 		$3.65M Sell
349,930
-13,596
-4% -$127K 0.02% 605
2023
Q3 		$3.71M Buy
363,526
+7,618
+2% +$70.9K 0.02% 568
2023
Q2 		$2.68M Buy
355,908
+11,400
+3% +$92.4K 0.01% 661
2023
Q1 		$3.05M Buy
344,508
+13,633
+4% +$135K 0.02% 596
2022
Q4 		$3.02M Buy
330,875
+38,200
+13% +$333K 0.02% 581
2022
Q3 		$2.36M Buy
292,675
+27,000
+10% +$239K 0.02% 634
2022
Q2 		$2M Hold
265,675
– – 0.01% 696
2022
Q1 		$2.49M Buy
265,675
+52,700
+25% +$440K 0.01% 676
2021
Q4 		$1.71M Hold
212,975
– – 0.01% 781
2021
Q3 		$2.07M Hold
212,975
– – 0.01% 700
2021
Q2 		$2.11M Buy
212,975
+23,700
+13% +$251K 0.01% 727
2021
Q1 		$2.18M Sell
189,275
-8,333
-4% -$95.6K 0.01% 691
2020
Q4 		$1.91M Buy
197,608
+9,100
+5% +$87.2K 0.01% 714
2020
Q3 		$1.7M Sell
188,508
-34,600
-16% -$366K 0.01% 668
2020
Q2 		$2.75M Sell
223,108
-8,500
-4% -$96.1K 0.02% 489
2020
Q1 		$2.08M Sell
231,608
-40,900
-15% -$419K 0.02% 492
2019
Q4 		$2.67M Buy
272,508
+23,200
+9% +$207K 0.02% 517
2019
Q3 		$1.72M Sell
249,308
-70,554
-22% -$541K 0.02% 631
2019
Q2 		$2.95M Buy
319,862
+46,200
+17% +$557K 0.03% 450
2019
Q1 		$4.29M Sell
273,662
-77,335
-22% -$1.36M 0.04% 350
2018
Q4 		$5.41M Buy
350,997
+45,500
+15% +$933K 0.06% 268
2018
Q3 		$6.58M Sell
305,497
-11,700
-4% -$272K 0.06% 258
2018
Q2 		$7.71M Buy
317,197
+60,933
+24% +$1.24M 0.08% 223
2018
Q1 		$4.38M Sell
256,264
-8,800
-3% -$172K 0.05% 304
2017
Q4 		$5.02M Sell
265,064
-107,700
-29% -$1.62M 0.06% 275
2017
Q3 		$6.56M Sell
372,764
-80,600
-18% -$1.81M 0.08% 221
2017
Q2 		$15.1M Sell
453,364
-3,200
-0.7% -$99K 0.2% 119
2017
Q1 		$14.7M Sell
456,564
-25,736
-5% -$878K 0.21% 116
2016
Q4 		$17.6M Buy
482,300
+48,677
+11% +$1.94M 0.32% 79
2016
Q3 		$20M Sell
433,623
-800
-0.2% -$41.7K 0.36% 70
2016
Q2 		$21.8M Buy
434,423
+8,300
+2% +$442K 0.41% 58
2016
Q1 		$22.8M Buy
426,123
+33,623
+9% +$1.97M 0.43% 61
2015
Q4 		$25.8M Sell
392,500
-32,700
-8% -$2.02M 0.5% 49
2015
Q3 		$24M Sell
425,200
-50,500
-11% -$3.27M 0.48% 53
2015
Q2 		$28.1M Buy
475,700
+7,800
+2% +$481K 0.52% 51
2015
Q1 		$29.1M Sell
467,900
-100
-0% -$5.81K 0.52% 49
2014
Q4 		$26.8M Sell
468,000
-10,500
-2% -$585K 0.47% 60
2014
Q3 		$25.6M Buy
478,500
+40,000
+9% +$2.12M 0.45% 67
2014
Q2 		$23.1M Buy
438,500
+30,600
+8% +$1.56M 0.43% 67
2014
Q1 		$21.5M Sell
407,900
-99,200
-20% -$4.58M 0.39% 67
2013
Q4 		$20.3M Buy
507,100
+27,300
+6% +$1.07M 0.37% 71
2013
Q3 		$18.1M Buy
479,800
+55,700
+13% +$2.17M 0.34% 78
2013
Q2 		$16.6M Buy
+424,100
New +$16.5M 0.33% 71

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Nomura Asset Management's TEVA Position: Q2 2026 in Review

Nomura Asset Management increased its Teva Pharmaceuticals (TEVA) stake by 5.5% in Q2 2026, buying an estimated $670K and bringing the position to 384,707 shares worth $13M. The position accounts for 0.03% of the portfolio, ranked #410.

Nomura Asset Management first reported a position in TEVA in Q2 2013 and has held it in 53 quarters since. The position peaked at $29.1M in Q1 2015. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Nomura Asset Management held 384,707 shares of Teva Pharmaceuticals worth $13M as of Q2 2026.
  • Nomura Asset Management bought 20,120 Teva Pharmaceuticals shares in Q2 2026, an estimated $670K.
  • Teva Pharmaceuticals made up 0.03% of Nomura Asset Management's portfolio in Q2 2026, its #410 holding.
  • Nomura Asset Management first reported a position in Teva Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Nomura Asset Management's Teva Pharmaceuticals position peaked at $29.1M in Q1 2015.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Nomura Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.